Increased DYRK1A levels resulting from gene duplication, such as in Trisomy 21 or Down's Syndrome, are characterised by neurogenic and neurodevelopmental defects, congenital heart defects, leukaemia, and early onset neurodegenerative disease. The gene discussed is DYRK1A; the disease is Down syndrome.